This could represent increased penetrance of MDS/AML development in male DDX41 germline mutation carriers, however the biological mechanism of this phenomenon is unexplored and, given the higher proportion of hematologic malignancy in white males as well as their population majority, additional population and family studies are needed. This evidence concerns the gene DDX41 and myelodysplastic syndrome.